Neurobiology of the use of selective serotonin reuptake inhibitors during pregnancy.
Friedman
E H
EH
D000818:Animals; D001143:Arousal / Q000187:drug effects / Q000502:physiology; D001921:Brain / Q000187:drug effects* / Q000196:embryology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D051379:Mice; D018377:Neurotransmitter Agents / Q000378:metabolism*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000503:physiopathology; D011297:Prenatal Exposure Delayed Effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D004298:Dopamine; D018377:Neurotransmitter Agents; D017367:Selective Serotonin Reuptake Inhibitors